Nuria Caballol Pons

Agomelatine for Depression in Parkinson Disease: Additional Effect on Sleep and Motor Dysfunction

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinsons disease.

Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy

Cognitive dysfunction and dementia in Parkinson disease

Combined CSF a-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.

Comparison of the Results of a Parkinsons Holter Monitor With Patient Diaries, in Real Conditions of Use: A Sub-analysis of the MoMoPa-EC Clinical Trial.

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain 2015), a global—clinical evaluations, serum biomarkers, genetic studies and neuroimaging—prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression

Discovering the 3’ UTR-mediated regulation of alpha-synuclein

Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program.

Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinsons disease.

Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.

MRI and transcranial sonography findings in Wilson disease

Myoclonus-dominant corticobasal degeneration

Paraneoplastic Encephalomyelitis With Glutamic Acid Decarboxylase Antibodies Presenting as Longitudinal Pyramidal Tract Hyperintensity.

Reduced striato-cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington’s disease patients

Simultaneous Classical and Holmes’ Tremor in Parkinson’s disease: Involvement of the Cerebellum

The prevalence of narcolepsy in Catalunya (Spain)